COVID ‐19 vaccines: What dermatologists should know?
Authors:
Open Access
- 13 July 2021
- journal article
- review article
- Published by Wiley in Dermatologic Therapy
- Vol. 34 (5) , e15056
Abstract
As COVID-19 vaccination has started worldwide to control this pandemic, dermatologists may face various challenges with these new vaccines. In this manuscript, we review different types of available COVID-19 vaccines and their various production platforms. Vaccination considerations in patients with skin diseases, especially those using immunomodulatory drugs will be presented. Finally, adverse cutaneous reactions of COVID-19 vaccines will be reviewed.Keywords
This publication has 42 references indexed in Scilit:
- An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatologyJournal of the American Academy of Dermatology, 2021
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJournal of the American Academy of Dermatology, 2021
- Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximabJournal of the American Academy of Dermatology, 2021
- ‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccineJournal of Travel Medicine, 2021
- COVID‐19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decisionBritish Journal of Dermatology, 2021
- European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologicsJournal of the European Academy of Dermatology and Venereology, 2021
- Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 updateAllergo Journal International, 2021
- Implication of mass COVID‐19 vaccination on dermatology practice in 2021Dermatologic Therapy, 2021
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020
- Risk of anaphylaxis after vaccination in children and adultsJournal of Allergy and Clinical Immunology, 2016